Insider Trading & Ownership of Steven M. Paul

Location: C/O Eli Litty & Co, LIIy Corporate Center Dc 1093, Indianapolis, IN
Summary: The estimated net worth of Steven M. Paul is at least $1.23M dollars as of September 15, 2025. Steven M. Paul is the Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $1.04M. Steven M. Paul is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $185K.
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Steven M. Paul files a new Insider Trading report.

Ownership of Steven M. Paul

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
RAPP	Rapport Therapeutics, Inc.	Director	$1.04M	+$1.03M	+7700%	Sep 12, 2025
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Director	$185K			Apr 1, 2022
KRTX	Karuna Therapeutics, Inc.	Director	$0			Mar 18, 2024
SAGE	Sage Therapeutics, Inc.	Director				Jan 3, 2024
VYGR	Voyager Therapeutics, Inc.	Director				Jun 3, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.